Accuray Incorporated

Accuray Incorporated

$2.28
0.1 (4.65%)
London Stock Exchange
USD, US
Medical - Equipment & Services

0H8I.L Price Chart

Basic
Market Cap$185.04M
Price$2.28
52 Week Range1.84-4.2614
Beta1.40
Margins
Gross Profit Margin31.04%
Operating Profit Margin-0.87%
Net Profit Margin-3.72%
Valuation (TTM)
P/E Ratio-13.76
Price to Sales Ratio0.51
Price to Book Ratio5.03
PEG Ratio2.20

Industry

Medical - Equipment & Services

Sector

Healthcare

Full-Time Employees

987

IPO Date

2018-01-29T00:00:00.000Z

Description

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.

Phone

408 716 4600

Address

1310 Chesapeake Terrace, Sunnyvale, CA, 94089, US

CIK